Skip to main content

Chugai Pharmaceuticals Value Stock - Dividend - Research Selection

Chugai Pharmaceuticals Co., Ltd.

ISIN: JP3519400000, WKN: 857216

Market price date: 25.01.2022
Market price: 3.698,00 JPY

Chugai Pharmaceuticals Co., Ltd. Fundamental data and company key figures of the share

Annual reports in JPY
Key figures 15-06-2021
Cash flow
Net operating cash flow
Capital Expenditures -
Free cash flow 148.060.995.584
Balance sheet
Total Equity 980.003.000.000
Liabilities & Shareholders equity 1.235.500.000.000
Income statement
Net income 214.733.000.000
Eps (diluted) 130,530
Diluted shares outstanding 1.645.000.000
Net sales/revenue 786.945.000.000

Fundamental ratios calculated on: 25-01-2022

Key figures 25-01-2022
Cash flow
P/C 29,66
P/FC 41,09
Balance sheet
Income statement
Div. Yield1,49%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization58.649.178.112,00 USD
IndicesNIKKEI 225,MSCI World Index
Raw Data SourceIFRS in Millionen JPY
Stock Split2020-06-29,3.000000/1.000000

Description of the company

CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Domestic segment is engaged in the sale of pharmaceutical products manufactured by the Company through its nationwide appointed stores. This segment is also involved in the research, development, transportation and storage of pharmaceutical products, as well as the provision of literature research services for pharmaceutical information. The Overseas segment is engaged in the sale of its pharmaceutical products in oversea markets, such as Germany, the United Kingdom, France, Taiwan, China Mainland, Korea and the United States. This segment is also involved in the provision of pharmaceutical academic information, as well as the research, development and registration of pharmaceutical products. As of December 31, 2013, the Company had 20 subsidiaries.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,